Financhill
Sell
40

INSP Quote, Financials, Valuation and Earnings

Last price:
$127.89
Seasonality move :
7.92%
Day range:
$129.00 - $132.04
52-week range:
$123.00 - $225.00
Dividend yield:
0%
P/E ratio:
60.03x
P/S ratio:
4.72x
P/B ratio:
6.04x
Volume:
767.4K
Avg. volume:
601K
1-year change:
-6.21%
Market cap:
$3.8B
Revenue:
$802.8M
EPS (TTM):
$2.17

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
INSP
Inspire Medical Systems
$214.5M $0.21 9.5% -28.13% $211.86
ELMD
Electromed
$16.4M -- 12.26% -- $33.50
IRIX
IRIDEX
$12.8M -$0.12 -2.72% -18.18% --
MYO
Myomo
$9.1M -$0.11 21.62% -253.33% $8.70
STXS
Stereotaxis
$7.8M -$0.07 72.15% -3.57% $4.50
TMDX
TransMedics Group
$147.8M $0.43 28.29% 22.47% $137.71
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
INSP
Inspire Medical Systems
$130.26 $211.86 $3.8B 60.03x $0.00 0% 4.72x
ELMD
Electromed
$19.30 $33.50 $161.9M 24.43x $0.00 0% 2.82x
IRIX
IRIDEX
$1.02 -- $17.1M -- $0.00 0% 0.35x
MYO
Myomo
$2.06 $8.70 $74.1M -- $0.00 0% 2.08x
STXS
Stereotaxis
$2.27 $4.50 $195.2M -- $0.00 0% 7.12x
TMDX
TransMedics Group
$116.88 $137.71 $4B 85.94x $0.00 0% 8.74x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
INSP
Inspire Medical Systems
-- 0.711 -- 7.28x
ELMD
Electromed
-- 2.259 -- 4.79x
IRIX
IRIDEX
81.05% 1.324 21.92% 1.11x
MYO
Myomo
-- -0.171 -- 2.24x
STXS
Stereotaxis
-- 2.022 -- 0.62x
TMDX
TransMedics Group
65.7% 3.189 22.41% 8.13x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
INSP
Inspire Medical Systems
$170.6M -$1.5M 10.24% 10.24% -0.74% -$15.1M
ELMD
Electromed
$12.2M $2.1M 16.57% 16.57% 13.65% $2.2M
IRIX
IRIDEX
$5.1M -$205K -140.14% -218.69% -1.72% -$1.2M
MYO
Myomo
$6.6M -$3.5M -38.11% -38.11% -35.81% -$3.3M
STXS
Stereotaxis
$4.1M -$5.9M -174.6% -174.6% -79.35% -$1.8M
TMDX
TransMedics Group
$88.2M $27.4M 6.8% 23.22% 21% -$29.9M

Inspire Medical Systems vs. Competitors

  • Which has Higher Returns INSP or ELMD?

    Electromed has a net margin of 1.49% compared to Inspire Medical Systems's net margin of 12.06%. Inspire Medical Systems's return on equity of 10.24% beat Electromed's return on equity of 16.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    INSP
    Inspire Medical Systems
    84.75% $0.10 $635.7M
    ELMD
    Electromed
    77.97% $0.21 $43.9M
  • What do Analysts Say About INSP or ELMD?

    Inspire Medical Systems has a consensus price target of $211.86, signalling upside risk potential of 62.65%. On the other hand Electromed has an analysts' consensus of $33.50 which suggests that it could grow by 73.58%. Given that Electromed has higher upside potential than Inspire Medical Systems, analysts believe Electromed is more attractive than Inspire Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    INSP
    Inspire Medical Systems
    8 5 0
    ELMD
    Electromed
    2 0 0
  • Is INSP or ELMD More Risky?

    Inspire Medical Systems has a beta of 1.247, which suggesting that the stock is 24.664% more volatile than S&P 500. In comparison Electromed has a beta of 0.413, suggesting its less volatile than the S&P 500 by 58.696%.

  • Which is a Better Dividend Stock INSP or ELMD?

    Inspire Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems pays -- of its earnings as a dividend. Electromed pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INSP or ELMD?

    Inspire Medical Systems quarterly revenues are $201.3M, which are larger than Electromed quarterly revenues of $15.7M. Inspire Medical Systems's net income of $3M is higher than Electromed's net income of $1.9M. Notably, Inspire Medical Systems's price-to-earnings ratio is 60.03x while Electromed's PE ratio is 24.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems is 4.72x versus 2.82x for Electromed. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INSP
    Inspire Medical Systems
    4.72x 60.03x $201.3M $3M
    ELMD
    Electromed
    2.82x 24.43x $15.7M $1.9M
  • Which has Higher Returns INSP or IRIX?

    IRIDEX has a net margin of 1.49% compared to Inspire Medical Systems's net margin of -14.17%. Inspire Medical Systems's return on equity of 10.24% beat IRIDEX's return on equity of -218.69%.

    Company Gross Margin Earnings Per Share Invested Capital
    INSP
    Inspire Medical Systems
    84.75% $0.10 $635.7M
    IRIX
    IRIDEX
    42.49% -$0.10 $4.5M
  • What do Analysts Say About INSP or IRIX?

    Inspire Medical Systems has a consensus price target of $211.86, signalling upside risk potential of 62.65%. On the other hand IRIDEX has an analysts' consensus of -- which suggests that it could grow by 96.08%. Given that IRIDEX has higher upside potential than Inspire Medical Systems, analysts believe IRIDEX is more attractive than Inspire Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    INSP
    Inspire Medical Systems
    8 5 0
    IRIX
    IRIDEX
    0 0 0
  • Is INSP or IRIX More Risky?

    Inspire Medical Systems has a beta of 1.247, which suggesting that the stock is 24.664% more volatile than S&P 500. In comparison IRIDEX has a beta of 0.566, suggesting its less volatile than the S&P 500 by 43.407%.

  • Which is a Better Dividend Stock INSP or IRIX?

    Inspire Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems pays -- of its earnings as a dividend. IRIDEX pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INSP or IRIX?

    Inspire Medical Systems quarterly revenues are $201.3M, which are larger than IRIDEX quarterly revenues of $11.9M. Inspire Medical Systems's net income of $3M is higher than IRIDEX's net income of -$1.7M. Notably, Inspire Medical Systems's price-to-earnings ratio is 60.03x while IRIDEX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems is 4.72x versus 0.35x for IRIDEX. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INSP
    Inspire Medical Systems
    4.72x 60.03x $201.3M $3M
    IRIX
    IRIDEX
    0.35x -- $11.9M -$1.7M
  • Which has Higher Returns INSP or MYO?

    Myomo has a net margin of 1.49% compared to Inspire Medical Systems's net margin of -35.24%. Inspire Medical Systems's return on equity of 10.24% beat Myomo's return on equity of -38.11%.

    Company Gross Margin Earnings Per Share Invested Capital
    INSP
    Inspire Medical Systems
    84.75% $0.10 $635.7M
    MYO
    Myomo
    67.23% -$0.08 $21.7M
  • What do Analysts Say About INSP or MYO?

    Inspire Medical Systems has a consensus price target of $211.86, signalling upside risk potential of 62.65%. On the other hand Myomo has an analysts' consensus of $8.70 which suggests that it could grow by 322.33%. Given that Myomo has higher upside potential than Inspire Medical Systems, analysts believe Myomo is more attractive than Inspire Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    INSP
    Inspire Medical Systems
    8 5 0
    MYO
    Myomo
    3 0 0
  • Is INSP or MYO More Risky?

    Inspire Medical Systems has a beta of 1.247, which suggesting that the stock is 24.664% more volatile than S&P 500. In comparison Myomo has a beta of 1.389, suggesting its more volatile than the S&P 500 by 38.863%.

  • Which is a Better Dividend Stock INSP or MYO?

    Inspire Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems pays -- of its earnings as a dividend. Myomo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INSP or MYO?

    Inspire Medical Systems quarterly revenues are $201.3M, which are larger than Myomo quarterly revenues of $9.8M. Inspire Medical Systems's net income of $3M is higher than Myomo's net income of -$3.5M. Notably, Inspire Medical Systems's price-to-earnings ratio is 60.03x while Myomo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems is 4.72x versus 2.08x for Myomo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INSP
    Inspire Medical Systems
    4.72x 60.03x $201.3M $3M
    MYO
    Myomo
    2.08x -- $9.8M -$3.5M
  • Which has Higher Returns INSP or STXS?

    Stereotaxis has a net margin of 1.49% compared to Inspire Medical Systems's net margin of -77.93%. Inspire Medical Systems's return on equity of 10.24% beat Stereotaxis's return on equity of -174.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    INSP
    Inspire Medical Systems
    84.75% $0.10 $635.7M
    STXS
    Stereotaxis
    54.39% -$0.07 $8.2M
  • What do Analysts Say About INSP or STXS?

    Inspire Medical Systems has a consensus price target of $211.86, signalling upside risk potential of 62.65%. On the other hand Stereotaxis has an analysts' consensus of $4.50 which suggests that it could grow by 98.24%. Given that Stereotaxis has higher upside potential than Inspire Medical Systems, analysts believe Stereotaxis is more attractive than Inspire Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    INSP
    Inspire Medical Systems
    8 5 0
    STXS
    Stereotaxis
    2 0 0
  • Is INSP or STXS More Risky?

    Inspire Medical Systems has a beta of 1.247, which suggesting that the stock is 24.664% more volatile than S&P 500. In comparison Stereotaxis has a beta of 1.440, suggesting its more volatile than the S&P 500 by 43.964%.

  • Which is a Better Dividend Stock INSP or STXS?

    Inspire Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems pays -- of its earnings as a dividend. Stereotaxis pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INSP or STXS?

    Inspire Medical Systems quarterly revenues are $201.3M, which are larger than Stereotaxis quarterly revenues of $7.5M. Inspire Medical Systems's net income of $3M is higher than Stereotaxis's net income of -$5.8M. Notably, Inspire Medical Systems's price-to-earnings ratio is 60.03x while Stereotaxis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems is 4.72x versus 7.12x for Stereotaxis. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INSP
    Inspire Medical Systems
    4.72x 60.03x $201.3M $3M
    STXS
    Stereotaxis
    7.12x -- $7.5M -$5.8M
  • Which has Higher Returns INSP or TMDX?

    TransMedics Group has a net margin of 1.49% compared to Inspire Medical Systems's net margin of 17.89%. Inspire Medical Systems's return on equity of 10.24% beat TransMedics Group's return on equity of 23.22%.

    Company Gross Margin Earnings Per Share Invested Capital
    INSP
    Inspire Medical Systems
    84.75% $0.10 $635.7M
    TMDX
    TransMedics Group
    61.47% $0.70 $776.4M
  • What do Analysts Say About INSP or TMDX?

    Inspire Medical Systems has a consensus price target of $211.86, signalling upside risk potential of 62.65%. On the other hand TransMedics Group has an analysts' consensus of $137.71 which suggests that it could grow by 16.24%. Given that Inspire Medical Systems has higher upside potential than TransMedics Group, analysts believe Inspire Medical Systems is more attractive than TransMedics Group.

    Company Buy Ratings Hold Ratings Sell Ratings
    INSP
    Inspire Medical Systems
    8 5 0
    TMDX
    TransMedics Group
    5 3 0
  • Is INSP or TMDX More Risky?

    Inspire Medical Systems has a beta of 1.247, which suggesting that the stock is 24.664% more volatile than S&P 500. In comparison TransMedics Group has a beta of 2.059, suggesting its more volatile than the S&P 500 by 105.891%.

  • Which is a Better Dividend Stock INSP or TMDX?

    Inspire Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TransMedics Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems pays -- of its earnings as a dividend. TransMedics Group pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INSP or TMDX?

    Inspire Medical Systems quarterly revenues are $201.3M, which are larger than TransMedics Group quarterly revenues of $143.5M. Inspire Medical Systems's net income of $3M is lower than TransMedics Group's net income of $25.7M. Notably, Inspire Medical Systems's price-to-earnings ratio is 60.03x while TransMedics Group's PE ratio is 85.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems is 4.72x versus 8.74x for TransMedics Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INSP
    Inspire Medical Systems
    4.72x 60.03x $201.3M $3M
    TMDX
    TransMedics Group
    8.74x 85.94x $143.5M $25.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Can SharkNinja Stock Go?
How High Can SharkNinja Stock Go?

If you know popular consumer appliance brands Shark and Ninja,…

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
77
VBTX alert for Jul 15

Veritex Holdings [VBTX] is down 3.26% over the past day.

Buy
72
MNPR alert for Jul 15

Monopar Therapeutics [MNPR] is down 8.6% over the past day.

Buy
56
NBIS alert for Jul 15

Nebius Group NV [NBIS] is up 2.98% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock